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Abstract
Transmissible gastroenteritis virus (TGEV) genome contains three accessory genes: 3a, 3b and 7. Gene 7 is only present in
members of coronavirus genus a1, and encodes a hydrophobic protein of 78 aa. To study gene 7 function, a recombinant
TGEV virus lacking gene 7 was engineered (rTGEV-D7). Both the mutant and the parental (rTGEV-wt) viruses showed the
same growth and viral RNA accumulation kinetics in tissue cultures. Nevertheless, cells infected with rTGEV-D7 virus showed
an increased cytopathic effect caused by an enhanced apoptosis mediated by caspase activation. Macromolecular synthesis
analysis showed that rTGEV-D7 virus infection led to host translational shut-off and increased cellular RNA degradation
compared with rTGEV-wt infection. An increase of eukaryotic translation initiation factor 2 (eIF2a) phosphorylation and an
enhanced nuclease, most likely RNase L, activity were observed in rTGEV-D7 virus infected cells. These results suggested
that the removal of gene 7 promoted an intensified dsRNA-activated host antiviral response. In protein 7 a conserved
sequence motif that potentially mediates binding to protein phosphatase 1 catalytic subunit (PP1c), a key regulator of the
cell antiviral defenses, was identified. We postulated that TGEV protein 7 may counteract host antiviral response by its
association with PP1c. In fact, pull-down assays demonstrated the interaction between TGEV protein 7, but not a protein 7
mutant lacking PP1c binding motif, with PP1. Moreover, the interaction between protein 7 and PP1 was required, during the
infection, for eIF2a dephosphorylation and inhibition of cell RNA degradation. Inoculation of newborn piglets with rTGEV-
D7 and rTGEV-wt viruses showed that rTGEV-D7 virus presented accelerated growth kinetics and pathology compared with
the parental virus. Overall, the results indicated that gene 7 counteracted host cell defenses, and modified TGEV persistence
increasing TGEV survival. Therefore, the acquisition of gene 7 by the TGEV genome most likely has provided a selective
advantage to the virus.
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Introduction
The order Nidovirales comprises enveloped single-stranded,
positive-sense RNA viruses. The Nidovirales includes the Coronavir-
idae that contains viruses with the largest known RNA genome, of
around 30 Kb [1,2]. Coronaviruses (CoVs) have been classified
into 3 genera, a, b and c {de Groot, 2010 #9759}. They are the
causative agents of a variety of human and animal diseases. In
humans, CoVs produce respiratory tract infections, causing from
the common cold to severe pneumonia and acute respiratory
distress syndrome (ARDS) that may result in death [3,4,5]. In
animals, CoVs also cause life-threatening diseases, such as severe
enteric and respiratory tract infections, and are economically
important pathogens [6]. Nevertheless, there is limited informa-
tion about the molecular mechanisms governing CoV virulence
and pathogenesis.
Double-stranded RNA (dsRNA), produced by RNA viruses as a
replication intermediate, is the pathogen-associated molecular
pattern that mediates the activation of a well-characterized
antiviral mechanism leading to viral protein synthesis shut down
[7]. This pathway includes the activation of double-stranded
RNA-dependent protein kinase (PKR), leading to eukaryotic
translation initiation factor 2 (eIF2a) phosphorylation, and the
activation of the 29-59-oligoadenylate synthetase (29-59OAS) and
its effector enzyme, the ribonuclease L (RNase L), responsible for
RNA degradation [8,9,10,11,12]. Due to the deleterious effects of
this response on virus survival, many viruses have developed
different strategies that counteract the host antiviral response
triggered by the dsRNA. These mechanisms are mediated by viral
proteins or RNAs [13,14,15,16,17,18,19,20,21,22], or by the
modification of cellular components [23,24,25,26,27].
CoV replication occurs in the cytoplasm, leading to dsRNA
species that trigger the host antiviral response. To overcome these
defenses, CoVs have developed several strategies. A general
mechanism for all CoVs is the induction of structures in infected
cells that may hide viral RNAs from the cellular sensors [28,29].
Some CoVs downregulate host gene expression. In fact, it has
been proposed that genus b CoV non structural protein (nsp)1
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.  Sprotein promotes host mRNA degradation in order to suppress
host innate immune response [30,31]. Severe acute respiratory
syndrome (SARS)-CoV nsp1 has also been involved in the
inhibition of the 40S ribosomal subunit translational activity
[30]. Moreover, several CoVs may also prevent the translational
shutoff due to the antiviral response, using viral components or
modulating cellular factors. Infectious bronchitis virus (IBV) nsp2
acts as a PKR antagonist [32], and MHV N protein antagonizes
29-59 OAS activity [33]. IBV also induces the over-expression of
growth arrest DNA-damage 34 (GADD34) protein, which
participates in eIF2a dephosphorylation [32].
The 59 two thirds of CoV genome encode the replicase proteins
that are expressed from two overlapping open reading frames
(ORFs) 1a and 1b [34]. The 39 one third of the genome contains
the genes encoding structural proteins and a set of accessory genes,
whose sequence and number differ between the different species of
CoV [1,35]. Traditionally, CoV accessory genes have been related
to virulence modulation, such as mouse hepatitis virus (MHV)
gene 5a that determines the interferon (IFN) resistance of the
different MHV strains [36]. SARS-CoV contains the largest
number of accessory genes and it has been proposed that these
genes could be responsible for its high virulence [37,38]. The role
of some structural genes, such as SARS-CoV genes E and 6, on
CoV pathogenesis has been demonstrated [39,40,41,42]. Never-
theless, the role of other SARS-CoV accessory genes in virus
replication and pathogenesis is still under study, as SARS-CoV
mutants lacking different combinations of these genes revealed
that they had limited impact on virus replication and pathogenesis
[37,38].
TGEV is a genus a1 CoV that contains three accessory genes:
3a, 3b and 7 [43,44,45]. The deletion of gene cluster 3ab
demonstrated that these genes were not essential for in vitro and in
vivo viral replication [45]. TGEV gene 7 is located at the 39end of
the genome, being the last ORF. In general, ORFs located in CoV
genomes downstream of nucleocapsid (N) gene have been named
as gene 7. And, one to three genes, 7a, 7b and 7c, have been
described for several CoVs of genus a, b4 and c3 at the end of
their genomes [35,46,47] [48]. Nevertheless, most of these genes
are not related to each other (J.L.G. Cruz, S. Zun ˜iga and L.
Enjuanes, unpublished observations). In fact, new genes located in
avian CoVs genomes after the N gene have been named
differently as they showed no sequence homology to any other
CoV genes [49]. TGEV protein 7 is similar to protein 7a of CoV
genus a1, with a 72% homology to feline infectious peritonitis
virus (FIPV), canine (CCoV) and porcine respiratory (PRCV)
CoVs 7a proteins (Figure 1A) [50,51]. The function of protein 7
has not been identified, and it has been proposed that it could play
a role in virulence [52,53]. The 7ab cluster deletion in FIPV
(FIPV-D7ab) resulted in virus attenuation [54]. Nevertheless, the
specific role that gene 7a plays in attenuation is not clear, as FIPV-
D7ab phenotype was similar to the one observed for a FIPV isolate
lacking only gene 7b [55].
To study gene 7 function, a recombinant TGEV virus missing
gene 7 was engineered. This deletion mutant virus induced an
intensified host antiviral response, including enhanced nuclease
activity and eIF2a phosphorylation, leading to an increase in cell
death by apoptosis. The interaction of TGEV protein 7 with PP1c
was also demonstrated. Inoculation of piglets with gene 7 deletion
mutant and wild-type viruses showed that virus missing gene 7
produced accelerated growth kinetics and pathology compared
with that caused by the parental virus. Overall, these results
indicate that TGEV gene 7 is a virulence gene that modulates host
cell defenses and extends the period of virus dissemination.
Results
Generation of recombinant TGEV virus (rTGEV) lacking
gene 7
TGEV ORF 7 encodes a 78 amino acid hydrophobic protein.
The structure predicted for protein 7 contains two transmembrane
domains (TM) at the amino- (aa 1–18) and carboxy-termini (aa
60–78), of the protein. The N-terminal TM domain overlaps with
a signal peptide (aa 1–24) (Figure 1A). The predicted membrane
topology locates the middle part of the protein towards the lumen
of a membrane structure (Figure 1A). During TGEV infection,
protein 7 was detected associated to the endoplasmatic reticulum
(ER) and plasma membranes [56].
To study the role of protein 7 during TGEV infection, an
rTGEV virus lacking gene 7 (rTGEV-D7) was engineered
(Figure 1B) [57]. To avoid gene 7 expression, several modifications
that led to an inactive ORF7 transcription regulating core
sequence (CS) were introduced (Figure 1B, left panel). The two
first nts of protein 7 translation start codon were also removed
(Figure 1B, left panel). These mutations introduced into the
TGEV infectious cDNA, were predicted to knock down gene 7
expression with minimum alteration to the 39end of the viral
genome, which is required for viral replication [58,59]. All the
mutations introduced in the cDNA were present in the recovered
rTGEV-D7 virus, after 6 passages in tissue culture of a plaque-
purified virus, indicating that they were stably maintained in the
rTGEV genome. The absence of subgenomic mRNA-7 in
rTGEV-D7 infected cells was confirmed by Northern-blot
(Figure 1B, right panel). Viral titer and genomic RNA (gRNA)
levels were analyzed. Intracellular RNA was only analyzed during
those times post infection in which viable cells were bound to the
plate (up to 24 hpi). Both mutant and parental viruses showed the
same virus growth kinetics and gRNA accumulation (Figure 1C).
The rTGEV-D7 virus titer decreased after 24 hours post infection
(hpi) due to the absence of live cells. This result was expected,
rTGEV-D7 virus titer decreased at a ratio of 1 log unit per day due
to thermal instability and to the absence of viable cells, at this time
Author Summary
Innate immune response is the first line of antiviral
defense. Viruses have developed diverse strategies to
evade this deleterious response, ensuring their survival.
Several CoV accessory genes play a central role in these
pathways. Nevertheless, the molecular mechanisms by
which they exert their function are still unknown. The
generation of a rTGEV without gene 7 expression allowed
us to study the role of protein 7 in the modulation of the
antiviral response. The absence of protein 7 during TGEV
infection caused an enhanced apoptosis and a transla-
tional shutoff, due to an increased cellular RNA degrada-
tion and eIF2a phosphorylation. We identified a protein
phosphatase 1 (PP1) binding motif in protein 7, and a
TGEV protein 7-PP1 interaction was demonstrated. We
propose a novel mechanism to counteract dsRNA-induced
antiviral response by RNA viruses. In vitro results were in
agreement with the enhanced virulence of the gene 7
deletion mutant virus in infected piglets. Our results
demonstrated that protein 7 modifies TGEV virulence,
reducing virus pathology and increasing the period of
virus shedding. This effect also benefits the host decreas-
ing clinical disease and extending its survival. These
observations could justify the incorporation and mainte-
nance of gene 7 to genus a1 CoVs during their evolution.
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PLoS Pathogens | www.plospathogens.org 2 June 2011 | Volume 7 | Issue 6 | e1002090Figure 1. Generation of a recombinant TGEV virus lacking protein 7 expression (rTGEV-D7). (A) Genus a1 CoV protein 7a sequence
alignment, using T-COFFEE [135]. Protein 7a sequences from the canine (CCoV) and porcine respiratory (PRCV) CoVs, transmissible gastroenteritis
(TGEV) and feline infectious peritonitis (FIPV) viruses were used. GenBank accession numbers are ADB28914.1, ABG89313.1, CAA80842.1, and
CAA62190.1, respectively. In silico prediction of TGEV protein 7 domains is represented. Transmembrane domains (TM) are in green [PredictProtein,
[136]], the signal peptide in blue [Signal P3.0 Server, [137]], and a conserved phosphorilable Serine in red (S-Phos) [NetPhos 2.0 Server, [138]]. The
predicted topology of TGEV protein 7 is also represented in lower panel [PSORTII [139]]. Signal peptide cleavage is indicated by a red arrowhead. S-
Phos is indicated by a red star. (B) Mutations introduced to generate a rTGEV-D7 virus, right panel. The scheme of TGEV gRNA is shown in the upper
part. The white letters represent the CS. Nucleotide change is indicated with a blue square, and the deletion (D) as a white square. Northern blot of
subgenomic mRNAs (sgmRNAs) produced during rTGEV infections, right panel. ST cells were infected with rTGEV-wt (wt) and rTGEV-D7( D7) viruses,
at a moi of 5. Total RNA was extracted at 8 hpi. The sgmRNAs for the spike (S), 3a, envelope (E), membrane (M), nucleocapsid (N) proteins, and protein
7 were detected. (C) In vitro growth kinetics of the rTGEV viruses. ST cells were infected with the rTGEV-wt (wt, blue) and rTGEV-D7( D7, red) viruses, at
a moi of 5. Culture medium and total intracellular RNA were collected at different hours post infection. Intracellular RNA was only analyzed during
those hours post infection in which viable cells were bound to the plate. Viral titers (left panel), and genomic RNA (gRNA) amounts (right panel),
determined by RT-qPCR, were analyzed. Error bars represent the standard deviation from three independent experiments.
doi:10.1371/journal.ppat.1002090.g001
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confirmed that protein 7 was not essential for TGEV replication in
cell culture.
Cell death caused by rTGEV-D7 infection
The cytopathic effect (CPE), characterized by the rounding and
detachment of the cells, induced by rTGEV-D7 virus was similar
to that caused by the wild-type (rTGEV-wt) virus. Nevertheless, 2-
fold larger plaques were produced by rTGEV-D7( 4 m m
diameter), compared with those caused by the parental virus
(2 mm diameter) (data not shown). Accordingly, in rTGEV-D7
infected cells the infectious foci were larger than those observed in
rTGEV-wt infected ones at 16 hpi (Figure 2A, left panels). This
increased CPE progressed until almost no viable cells remained in
the rTGEV-D7 infection at 24 hpi (Figure 2A, right panels). The
cell death induced by the rTGEV-D7 virus was analyzed by
permeabilization, propidium iodide (PI) staining and flow
cytometry (Figure 2B). This technique distinguishes dying or
subdiploid cells from normal cells that emit a high PI fluorescence
signal [61,62]. As expected, the wild-type virus induced cell death
and DNA degradation during the infection (Figure 2B) [63].
Interestingly, rTGEV-D7 caused a significant increase in cell death
compared with that caused by rTGEV-wt infection (Figure 2B).
Apoptosis induced by rTGEV-D7 virus
The main cause of the cytopathic effect induced by TGEV
infection is apoptosis programmed cell death [63,64,65]. To
analyze whether the increased cell death during rTGEV-D7
infection was due to an enhanced apoptosis, cells infected either
with rTGEV-wt or rTGEV-D7 were simultaneously stained with
PI and Annexin V, and monitored by flow cytometry. Mock
infected cells remained viable (Annexin V
2,P I
2) throughout the
experiment, indicating that the treatment did not induce apoptosis
by itself (Figure 3A). As expected, the wild-type virus infection
induced apoptosis (Annexin V
+), and a cell population in late
apoptosis (Annexin V
+,P I
+) was evident at 12 hpi (Figure 3A).
Mutant rTGEV-D7 also triggered apoptosis but faster and
stronger than that caused by the rTGEV-wt virus, with a 2-fold
increase in apoptotic cells at 8 hpi and only 36% live cells at 12 hpi
(Figure 3A).
It has previously been reported that TGEV virus induces
apoptosis following a caspase dependent pathway that involves the
processing of two initiator proteases (caspase 8 and 9), as well as
three downstream effector caspases (caspase 3, 6 and 7) [64,65].
Caspase 3 activation leads to TGEV N protein cleavage [64], and
inhibition of caspase 3 processing, among others caspases, prevents
TGEV induced apoptosis [63]. To determine the potential
influence of gene 7 on caspase dependent apoptosis, the presence
of the processed form of caspase 3 was analyzed by Western-blot
using specific antibodies. TGEV infection induced the cleavage of
caspase 3 (Figure 3B) and, as a consequence, cleaved N protein
was also detected (data not shown), as expected [64]. Moreover,
the rTGEV-D7 triggered caspase 3 processing faster than the wild-
type virus. These results indicated that the increased CPE
observed in rTGEV-D7 infected cells was most likely due to an
enhanced apoptosis mediated by caspase activation.
Effect of gene 7 deletion on macromolecular synthesis
CoVs such as MHV or SARS-CoV, cause translational shutoff
and lead to apoptosis increase [30,66,67,68,69,70,71]. To
determine whether this was also the case for TGEV-D7 virus, de
novo protein synthesis during the infection was evaluated by
metabolic labeling. No translational stall was detected during
rTGEV-wt infection (Figure 4A), as described for other CoVs such
as IBV and bovine coronavirus (BCoV), or MHV at early times
post infection [32,33,72]. In contrast, rTGEV-D7 infection
inhibited host translational machinery, an effect detected from
10 hpi. This translational stop affected both cellular and viral
protein synthesis (Figure 4A). CoVs produce viral mRNAs that are
structurally similar to those produced by their host (59 CAP-
structure and poly A at the 39end), allowing CoVs to parasitize the
host translational machinery. In some CoVs, such as MHV,
selective viral protein synthesis occurs concomitantly with host
translational inhibition, using a mechanism not fully characterized
[73,74]. To study the mechanism responsible for protein synthesis
reduction in TGEV-D7 infection, and to analyze whether viral
mRNAs were preferentially translated, the amount of radiolabeled
N protein, taken as reference for viral protein synthesis, was
related to the total amount of protein (viral plus cellular) per well
(Figure 4B). The ratio of viral to total protein synthesis showed no
significant differences between rTGEV-wt and rTGEV-D7
infected cells (Figure 4B). In addition, no differences in viral
proteins accumulation were observed at this times post infection
(data not shown). These results suggested that protein synthesis at
early times post infection was responsible for the virus that was still
being produced after translational shutoff. This result suggested
that the absence of protein 7 during TGEV infection led to protein
synthesis inhibition most likely by inhibiting a cell translation step
common to cellular and viral protein synthesis.
In principle, RNA decay could be responsible for the observed
translational shutoff. Therefore, total cellular RNA integrity was
evaluated using a Bioanalyzer [75,76,77]. Wild-type virus infection
induced a modest RNA processing, especially at 24 hpi (Figure 5A).
In contrast, rTGEV-D7 infection induced a faster and stronger
cellular RNA degradation (Figure 5A). This data indicated that the
cellular translational shutoff could be due, at least in part, to
cellular mRNA degradation. Moreover, the increase in 28S rRNA
degradation (Figure 5B), could affect both cellular and viral
protein synthesis [78]. Nucleases activated by cell apoptosis could
be responsible for the observed RNA degradation [79]. To study
whether this was the case, we took advantage of the previous
description of the inhibition of TGEV induced apoptosis by the
addition of caspases inhibitor ZVAD, without affecting virus
production [63]. In fact, after infection of ST cells with wt or
rTGEV-D7 viruses in the presence of ZVAD, no CPE was
observed. Total RNA was extracted from non-treated or ZVAD-
treated cells, and the same RNA degradation patterns were
observed in both cases (Figure 5C), indicating that the increased
RNA degradation caused by rTGEV-D7 virus was independent of
nucleases activated by cell apoptosis. To determine whether the
observed cellular RNA cleavage was due to a dsRNA induced
antiviral response, ST cells were treated with polyinosinic-
polycytidylic acid [Poly(I:C)], which is a potent activator of this
type of response [77,80,81]. Cells transfected with Poly(I:C)
showed the same RNA degradation pattern as those infected with
the rTGEV-D7 and parental viruses (Figure 5D), in contrast to
mock treated cells. These results suggested that the cellular RNA
cleavage increase, during rTGEV-D7 infection, was due to an
enhancement of dsRNA induced antiviral activity. In general, the
main effector of this process is RNase L [81,82,83]. To further
analyze the relevance of this nuclease during TGEV infection, a
recombinant vaccinia virus (VV) system was used. It was
previously described that VV does not induce strong RNA
degradation, due to the presence of viral genes that inhibit the
RNase L system. To efficiently trigger dsRNA activated RNA
degradation by RNase L, cells must be infected by VV expressing
29-59 OAS and RNase L [84]. Taking advantage of the wide host
range of VV, porcine ST cells were infected with VV, or VVs
Role of Gene 7 on Host Antiviral Response
PLoS Pathogens | www.plospathogens.org 4 June 2011 | Volume 7 | Issue 6 | e1002090Figure 2. Cell death caused by rTGEV-D7. (A) ST cells were infected with rTGEV-wt and rTGEV-D7( D7) viruses. The cytophatic effect induced by
both viruses was analyzed by optical microscopy, at 12, 16 and 24 hpi. Images were taken with a 40x objective. (B) Quantification of cell death
induced by rTGEV viruses. ST cells were infected with rTGEV-wt (wt) and rTGEV-D7( D7) viruses. Cells were collected at 4, 8, 10, 12 and 16 hpi,
permeabilized, and stained with propidium iodide. Dead cell population was measured by flow cytometry. Error bars indicate the standard deviation
from three independent experiments. **, p-value,0.01.
doi:10.1371/journal.ppat.1002090.g002
Role of Gene 7 on Host Antiviral Response
PLoS Pathogens | www.plospathogens.org 5 June 2011 | Volume 7 | Issue 6 | e1002090Figure 3. Apoptosis caused by rTGEV-D7. (A) Apoptosis levels in mock, rTGEV-wt (wt) and rTGEV-D7( D7) infected cells were evaluated at 4, 8
and 12 hpi, by flow cytometry. Annexin V-PI double staining was performed to differentiate cells in early apoptosis (Annexin V
+,P I
2) from those in
late apoptosis (Annexin V
+,P I
+) stages. (B) Detection of active caspase 3 by Western-blot. Total protein was extracted from ST cells infected with
rTGEV-wt (wt) and rTGEV-D7( D7) viruses, at the indicated times post infection. Active caspase 3 was detected using specific antibodies for the cleaved
form. b-actin was detected as a loading control.
doi:10.1371/journal.ppat.1002090.g003
Role of Gene 7 on Host Antiviral Response
PLoS Pathogens | www.plospathogens.org 6 June 2011 | Volume 7 | Issue 6 | e1002090Figure 4. De novo protein synthesis in rTGEV infections. (A) At the indicated times post infection, ST cells were infected at a moi of 1 with
rTGEV-wt (wt) and rTGEV-D7( D7) viruses. Cells were labeled with
35S Met-Cys for 30 min. Protein extracts were obtained and SDS-PAGE
electrophoresis was performed to detect labeled proteins. Viral spike (S), nucleocapsid (N), and membrane (M) proteins are indicated. Densitometric
Role of Gene 7 on Host Antiviral Response
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very slight RNA degradation, that was increased by the co-
expression of 29-59 OAS and RNase L (Figure 5D). Moreover, the
RNA degradation pattern produced by the expression of RNase L
system was identical to the one observed after rTGEV-D7
infection, strongly suggesting that RNaseL is the main nuclease
involved in the increased RNA degradation after rTGEV-D7
infection.
The activation of RNase L requires its binding to small 59-
triphosphorylated,29-59-oligoadenylates (29-59A), generated by the
29-59A synthetase (29-59OAS) [10,11] (Figure 6A). In non-infected
cells 29-59OAS is expressed at background levels that are
significantly increased during some viral infections [85,86].
Therefore, 29-59OAS1 expression during infection by rTGEV-wt
and rTGEV-D7 was evaluated by quantitative RT-PCR (RT-
qPCR). TGEV-wt infection induced the expression of the 29-
59OAS1, as expected (Figure 6B) [87]. rTGEV-D7 infection also
activated this pathway. Nevertheless, the slight differences in 29-
59OAS1 gene expression between rTGEV-wt and rTGEV-D7
infections could not explain the enhanced nuclease activity
observed during mutant virus infection (Figure 6B), as 29-
59OAS1 mRNA level was even lower for rTGEV-D7 than for
rTGEV-wt virus (Figure 6B).
Viral mRNA levels were measured by RT-qPCR, as the ratio
between mRNA and gRNA amounts. No significant differences
were observed between rTGEV-D7 and rTGEV-wt viruses, for the
accumulation kinetics of both N and M protein mRNAs
(Figure 7A). Nevertheless, RT-qPCR evaluation did not rule out
whether viral rTGEV-D7 mRNAs could have been degraded, as
the cellular RNAs were. Therefore, viral RNA integrity was
evaluated by Northern blot assay. The total RNA amount loaded
from rTGEV-D7 infected cells was 1.5 to 2 fold higher than that
loaded from rTGEV-wt infected ones, in order to detect possible
degradation species. No degradation of viral mRNAs was detected
after infection by rTGEV-wt or rTGEV-D7 (Figure 7B), suggesting
that viral RNAs were not degraded by the increased nuclease
activity.
Effect of protein 7 absence on translation initiation
Several mechanisms may account for the observed translational
blockage. We have shown that the absence of protein 7 during
TGEV infection enhanced the degradation of cellular mRNAs and
ribosomal components. In addition, other factors could promote
translational stall. In fact, many viruses interact with translation
machinery components [88]. Eukaryotic initiation factor 4G
(eIF4G) is a well-characterized target of the TGEV-induced
apoptosis [64]. No difference was found in eIF4G processing at
different times post infection by wild-type or mutant viruses (data
not shown).
Protein synthesis is frequently reduced when cells are under
stress, such as that caused by virus infection, by increasing the
phosphorylation levels of the eIF2a subunit at serine 51 [89].
eIF2a phosphorylation, during rTGEV infection, was analyzed by
Western-blot using antibodies specific for the phosphorylated
(eIF2a-P) and total forms of this factor, respectively. Wild-type
infection increased eIF2a-P levels (Figure 8A), reaching a
maximum at 8 hpi (Figure 8B). As previously described, for other
stress conditions, eIF2a-P levels decreased at late times post-
infection [90,91]. Similarly, rTGEV-D7 infection also induced
eIF2a phosphorylation (Figure 8A) but to significantly higher
levels than those observed during rTGEV-wt infection (Figures 8A
and 8B). Interestingly, the highest difference was detected at 10
hpi, concomitantly with the time at which the mutant virus
induced the translational shutoff (Figure 8B). The increased eIF2a
phosphorylation was maintained, although at different levels, from
8hpi to 10 hpi, what could be sufficient to account for the
translational shutoff, according to previously published studies
[92,93]. Altogether, this result indicated that, besides cellular RNA
degradation, rTGEV-D7-induced translational shutoff is probably
due to an increased and sustained eIF2a phosphorylation.
Growth arrest DNA-damage 34 (GADD34) protein is induced
by cell stress, and its expression levels are upregulated on increased
eIF2a phosphorylation conditions [94]. Therefore, GADD34
mRNA levels could have been modified during rTGEV-D7
infection, and were quantified by RT-qPCR. Infection by
rTGEV-D7 virus induced significantly higher levels of GADD34
mRNA than the rTGEV-wt virus (Figure S1). This data correlated
with the previous results, as higher eIF2a-P levels, in mutant virus
infection, led to GADD34 increased expression.
Protein 7 provided in trans restored rTGEV-wt phenotype
To assess whether the absence of protein 7 during TGEV
infection was responsible for the observed phenotype, ST cells
stably expressing TGEV protein 7 (ST-HA-7) were generated. In
order to detect protein 7, a hemagglutinin (HA) tag was inserted
between the signal peptide and the rest of the protein (Figure 9A).
Protein 7 expression was confirmed by immunofluorescence and
Western-blot analysis (Figure 9B). Three ST-HA-7 cellular clones
(C1, C2 and C3), with different protein 7 expression levels were
selected (Figure 9B). The effect of protein 7 provided in trans on
apoptosis and cellular RNA degradation was analyzed. Infection of
ST cells by rTGEV-D7 caused a stronger apoptosis than the
rTGEV-wt virus, as previously observed (Figure 9C). Protein 7
provided in trans significantly reduced apoptosis both in rTGEV-
D7 infected cells and in rTGEV-wt infected ones (Figure 9C).
Moreover, infection of ST cells by rTGEV-D7 caused higher RNA
degradation than the rTGEV-wt virus, as previously described
(Figure 9D). The amount of protein 7 directly correlated with the
inhibition of RNA degradation, suggesting that protein 7
expression in trans prevented nuclease activation (Figure 9D).
Furthermore, GADD34 mRNA expression (Figure S2A) and
eIF2a phosphorylation levels (Figure S2B) were reduced by
protein 7 expression in trans. Altogether, these results demonstrated
that the specific phenotype of the rTGEV-D7 virus was due to
TGEV protein 7 absence, as it was reverted to the rTGEV-wt
phenotype, in a dose-dependent manner, by providing protein 7 in
trans.
Effect of protein 7 absence on the antiviral response
induced by dsRNA
The activation of an antiviral response pathway triggered by the
dsRNA produced during viral infections leads to eIF2a phosphor-
ylation that results in translational shutoff [10,95,96]. The dsRNA-
activated protein kinase (PKR) is a component of dsRNA induced
antiviral response. PKR dimerization, and subsequent activation
by autophosphorylation, is mediated by its binding to dsRNA [89].
analysis was performed to determine the levels of host protein synthesis. The boxes represent the region of the gel used for densitometry analysis,
and the numbers below represent the relative radioactivity compared with mock-infected cells. (B) Viral-to-cell protein synthesis ratio. The amount of
radiolabeled N protein, estimated by densitometry, was related to the estimated total amount of protein, at the indicated hpi. Error bars indicate the
standard deviation from three independent experiments. r.u., relative units.
doi:10.1371/journal.ppat.1002090.g004
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inhibition (Figure S3A) [9,12]. Infection by wild-type TGEV
induced PKR phosphorylation, with a maximum at 12 hpi (Figure
S3B). Nevertheless, no significant differences were observed
between rTGEV-wt and rTGEV-D7 virus infections, either in
PKR-phosphorylation levels or total PKR protein accumulation
(Figure S3B).
During viral infection, the accumulation of nascent or misfolded
proteins in the endoplasmic reticulum (ER) can trigger an ER
stress pathway, which could also lead to translational stall by eIF2a
phosphorylation (Figure S3A) [97]. PKR-like endoplasmic retic-
ulum kinase (PERK) is activated by ER stress, and could
participate in eIF2a phosphorylation during viral infection
[98,99]. Activation of PERK requires the prior activation of the
ER chaperone immunoglobulin heavy-chain binding protein (BiP),
a biomarker for the onset of the ER stress [100,101]. Similar levels
of BiP were observed in rTGEV-wt or in rTGEV-D7 infected cells
during infection (Figure S3B), suggesting that PERK would not be
differentially activated in the cells infected with the gene 7 deletion
mutant virus with respect to those infected with the parental virus.
These data strongly suggested that an increased kinase activity was
not responsible for the increased eIF2a phosphorylation during
rTGEV-D7 virus infection.
Interaction of protein 7 and PP1
The enhanced eIF2a phosphorylation observed during rTGEV-
D7 virus infection could be alternatively due to a decrease in the
phosphatase activity that counteracts the kinases function (Figure
S3A). Protein phosphatase 1 (PP1) is one of the major Ser/Thr
phosphatases, and is the main enzyme responsible of the eIF2a
dephosphorylation [32,94,102]. PP1 expression was evaluated by
Western-blot, and similar protein levels were detected in both
rTGEV-wt and rTGEV-D7 infected cells (Figure S3C).
The PP1 catalytic subunit (PP1c) can interact with more than 50
regulatory partners. The formation of these complexes determines
its substrate specificity, sub-cellular location and activity, allowing
PP1 to participate in numerous cellular functions [103,104].
Therefore, although a decrease in PP1 levels was not detected in
rTGEV-D7 infected cells, compared with rTGEV-wt infected
ones, protein 7 could modulate PP1 activity. To study this
possibility, the functional motifs of CoV genus a1 protein 7 were
analyzed using the ELM server [105,106]. A highly conserved
sequence at the C-terminus of the protein was identified as the
canonical PP1c-binding motif (Figure 10A). The consensus PP1c-
binding motif includes a short sequence (R/K)VxF, in which x is
any amino acid except those with large hydrophobic residues,
surrounded by non-polar residues (Figure 10B) [103]. Previous
Figure 6. Quantification of 29-59OAS expression during rTGEV infection. (A) Scheme of 29-59OAS/RNase L activation pathway. (B)
Quantification of porcine 29-59OAS mRNA accumulation during rTGEV-wt (blue) or rTGEV-D7 (red) infections, by RT-qPCR, at indicated time post
infection. r.u., relative units. Error bars indicate the standard deviation from three independent experiments.
doi:10.1371/journal.ppat.1002090.g006
Figure 5. Cellular RNA integrity. (A) Total RNA extracted from infected ST cells, at indicated times post infection, was analyzed using a
Bioanalyzer. The position of 28S and 18S rRNAs are indicated. (B) 28S rRNA integrity. Graph of 28S fluorescence intensity, as measured by Bioanalyzer,
in the RNA samples from ST cells infected with rTGEV-wt (blue) or rTGEV-D7 (red), collected at different times post infection. f.u., fluorescence units.
Error bars indicate the standard deviation from three independent experiments. *, p-value ,0.05. (C) ST cells were treated with caspase inhibitor
ZVAD, and infected. Total RNA was extracted and analyzed using a Bioanalyzer. (D) ST cells were transfected with Poly(I:C), and total RNA was
extracted 16 hours post transfection. ST cells were also infected with a vaccinia virus expressing T7 polymerase (T7), or with the vaccinia expressing
T7 polymerase, and two additional vaccinia viruses expressing 29-59 OAS and RNase L (RL+OAS). Total RNA was extracted 24 hpi. In all cases, cell RNA
integrity was analyzed using a Bioanalyzer.
doi:10.1371/journal.ppat.1002090.g005
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mediate PP1 binding, whereas the surrounding amino acids are
responsible for PP1 binding and allosteric modulation of the
enzyme activity [107,108,109]. This motif is also present in three
viral and several cell proteins, such as herpex simplex virus 1
c134.5, human papilomavirus E6 oncoprotein and African swine
fever virus DP71L, and mammalian GADD34 proteins
(Figure 10B). In all cases, these proteins bind PP1c and promote
Figure 7. Viral RNA integrity. (A) Quantification of viral N and M sg mRNAs accumulation during rTGEV-wt (blue) or rTGEV-D7 (red) infections by
RT-qPCR at indicated hpi. The ratio of sg mRNA to genomic RNA is represented. r.u., relative units. Error bars indicate the standard deviation from
three independent experiments. (B) Northern blot analysis of intracellular viral sg mRNAs. ST cells were infected with rTGEV-wt or rTGEV-D7 viruses.
Total RNA was extracted at indicated hours post infection and analyzed by Northern blot using a probe complementary to the 39 end of all sg mRNAs.
Total RNA amount loaded from rTGEV-D7 infected cells was 1.5 to 2 fold higher than that loaded from rTGEV-wt infected ones, in order to detect
possible degradation species. Viral mRNAs for the spike (S), 3a, envelope (E), membrane (M), nucleocapsid (N) proteins, and protein 7 are indicated on
the left.
doi:10.1371/journal.ppat.1002090.g007
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observed that both rTGEV-wt and rTGEV-D7 virus infections
trigger the cell antiviral response, leading to an increased eIF2a-P
level. We hypothesized that during rTGEV-wt infection protein 7
may interact through its PP1c-binding motif with the PP1
complex, promoting eIF2a dephosphorylation, leading to normal
protein synthesis (Figure 10C). In contrast, in rTGEV-D7
infection, the virus could not counteract the high eIF2a-P levels,
causing translational shutoff and cell damage (Figure 10C). TGEV
protein 7-PP1 interaction was evaluated using a pull-down assay
with ST-HA-7 cells extracts. Immunoprecipitation with anti-HA-
agarose followed by immunoblotting with anti-HA showed the
presence of protein 7 in both the ST-HA-7 input and
immunoprecipitated extracts, but not in ST cells extracts, as
expected (Figure 10D). Immunoblotting with anti-PP1 confirmed
that PP1c was pulled-down together with protein 7 (Figure 10D).
HA-tagged SARS-CoV E protein, which is also a small viral
membrane protein was used as a control bait for immunoprecip-
itation. The interaction between protein 7 and PP1 was specific, as
E protein did not co-immunoprecipitate PP1protein (Figure 10D).
Moreover, an HA-tagged protein 7 mutant, lacking PP1 binding
motif, did not co-immunoprecipitate PP1 protein. Altogether, this
results demonstrated TGEV protein 7-PP1 interaction. The
presence of eIF2a on the co-immunoprecipitated samples was
also analyzed. This factor was specifically co-immunoprecipitated
both by native and mutant TGEV protein 7 (Figure 10D),
suggesting that eIF2a was present in the complex formed by
TGEV protein 7 and PP1. Furthermore, the interaction between
protein 7 and PP1 was also evaluated in the context of TGEV
infection. ST-HA-7 cells were mock infected or infected with
rTGEV-D7, to avoid competition with the non-tagged protein 7
encoded by the wild-type virus. PP1 co-immunoprecipitated with
HA-tagged protein 7 in rTGEV-D7 infected cells (Figure S4),
indicating that TGEV protein 7 also interacts with PP1 in the
Figure 8. eIF2a phosphorylation during rTGEV infection. (A) Total protein was extracted, at indicated times post infection, from ST cells
infected at a moi of 5 with rTGEV-wt (wt) and rTGEV-D7( D7) viruses. Accumulation of total eIF2a and phosphorylated eIF2a (eIF2a-P), was analyzed by
Western-blot. (B) eIF2a and eIF2a-P amounts were estimated by densitometric analysis. The graph represented eIF2a/eIF2a-P ratio in mock (green),
rTGEV-wt (blue) and rTGEV-D7 (red) infected cells at indicated hpi. Error bars indicate the standard deviation from six independent experiments. r.u.,
relative units. *, p-value ,0.05; **, p-value ,0.01.
doi:10.1371/journal.ppat.1002090.g008
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HA-7 cells, a decrease in the PP1 co-immunoprecipitated by HA-
tagged protein 7 was observed in relation to the rTGEV-D7
infected cells (Figure S4B), indicating that protein 7, expressed
from rTGEV-wt virus, also interacts with PP1, and competed with
tagged HA-7 protein for the binding to PP1.
To further evaluate the role of the PP1-protein 7 interaction on
the rTGEV-D7 observed phenotype, RNA degradation and eIF2a
phosphorylation levels were analyzed in the presence of the
protein 7 mutant that did not bind to PP1. ST cells were
transfected with the HA-tagged protein 7 mutant, and the
expression of this protein was confirmed by immunofluorescence
(data not shown). As previously observed, rTGEV-D7 virus caused
an increased RNA degradation (Figure 11A) and eIF2a phos-
phorylation (Figure 11B). Interestingly, protein 7 mutant provided
in trans did not reduce the RNA degradation and eIF2a
phosphorylation caused by rTGEV-D7 virus (Figure 11), although
eIF2a was also pulled-down by protein 7 mutant. This data
strongly indicated that native TGEV protein 7 modulated RNA
degradation and eIF2a phosphorylation by its interaction with
PP1 protein, supporting our working hypothesis.
In vivo phenotype of rTGEV-D7
Newborn piglets were infected with rTGEV-wt and rTGEV-D7
viruses. Both viruses showed similar growth kinetics in the lung,
although gene 7 deletion mutant virus reached higher titers than
the parental virus at early times post infection (Figure 12A).
Virulent TGEV strains replicate in the villious epithelial cells of
the small intestine and in lung cells, causing severe diarrhea in
newborn piglets [57,114,115]. The respiratory and enteric tropism
of the rTGEVs can be modified by the introduction of an S gene
from a virulent strain [57,114,115]. The rTGEV-D7 deletion
mutant used throughout this paper was generated with an
exclusively respiratory tropism (see Materials and Methods). To
study the relevance of protein 7 in a virulent virus, a recombinant
virus with respiratory and enteric tropism, lacking the expression
of the gene 7 (rTGEV-SC11-D7) was engineered [57]. Growth in
lung of rTGEV-SC11-wt and rTGEV-SC11-D7 viruses was
similar to that of the previous mutant and wild-type viruses (data
not shown). Interestingly, the rTGEV-SC11-D7 showed acceler-
ated growth kinetics in gut, compared to the wild-type virus
(Figure 12B). This behavior correlated with more pronounced
clinical symptoms (Figure S5A). Both rTGEV-SC11-wt and
rTGEV-SC11-D7 infected animals had the same final survival
ratio (50%) (Figure S5B). Nevertheless, animals infected with
rTGEV-SC11-D7 died six days before that those infected with
rTGEV-SC11-wt (Figure S5B). Accordingly, virus was detected
only in sentinel animals in contact with rTGEV-wt infected piglets,
but not in those in close proximity to the rTGEV-SC11-D7
infected animals (Figure 12B). This result suggested that the
presence of protein 7 facilitated animal survival and virus
shedding.
Histopathology of lungs from animals infected with rTGEV-wt
and rTGEV-D7 viruses was analyzed. Lung injury caused by
rTGEV-wt consisted in alveolar wall thickening, emphysemas, and
obstruction of the conducting airways by cell debris (Figure 13).
rTGEV-D7 pathology at 1dpi was comparable with that observed
in piglets 4 days post rTGEV-wt infection, indicating that tissue
injury caused by the gene 7 deletion mutant virus was faster than
that due to the wild-type virus (Figure 13). In addition to the
lesions described in rTGEV-wt infected animals, in rTGEV-D7
infected tissue edema was also observed as a consequence of strong
alveolar congestion (Figure 13).
Virus antigen immunodetection showed the same infection
pattern for both viruses (Figure 13), and the active caspase 3
pattern overlapped with those areas in which viral infectious foci
were detected (Figure 13). Taken together the results indicated a
faster lung infection and more extensive injury caused by rTGEV-
D7 virus.
Discussion
This study shows that TGEV protein 7 modified the antiviral
response, and that the presence of gene 7 attenuated virus
virulence. TGEV infection led to the activation of an antiviral
pathway triggered by the dsRNA produced during the virus cycle
(Figure 14). This pathway has two main effectors: 29-59OAS that
leads to RNase L activation and RNA degradation, and PKR that
is responsible of eIF2a phosphorylation [116]. In general, the
activation of this pathway leads to blocking of the cell translational
machinery, and induction of caspase-dependent apoptosis of
infected and neighboring cells (Figure 14) [8,10]. Interestingly,
we have shown that TGEV protein 7 bound PP1, a key regulator
of the cell antiviral defenses, and we proposed that this binding
modulates dsRNA-activated pathway.
In rTGEV-D7 infected cells, an increased eIF2a phosphoryla-
tion was observed over rTGEV-wt infection, although enhanced
kinase activation was not detected. Interaction of protein 7 with
the PP1c complex may counteract PKR activity (Figure 14). This
is a novel mechanism not previously observed in the RNA viruses.
Nevertheless, a similar mechanism was previously described for
three DNA virus proteins containing a PP1c-binding motif,
encoded by herpex simplex virus-1 (c134.5 protein), papilomavirus
(E6 protein) and African swine fever virus (DP71L protein)
(Figure 10B) [102,110,111]. These proteins counteract the
negative effect of the eIF2a phosphorylation on cellular and viral
protein synthesis through their interaction with the PP1 complex.
This interaction promotes dephosphorylation of eIF2a
[102,110,111]. In fact, while native TGEV protein 7 provided in
trans decreased eIF2a phosphorylation, a protein 7 mutant that did
not bound PP1 was unable to reduce eIF2a phosphorylation
levels.
The evaluation of cellular RNA integrity in rTGEV-D7 infected
cells revealed an increase of cellular RNA degradation compared
with rTGEV-wt virus infected cells. The degradation pattern was
Figure 9. Complementation of rTGEV-D7 produced apoptosis and RNA degradation by protein 7 provided in trans. Generation of ST
cells expressing TGEV protein 7 in trans. (A) Scheme of TGEV protein 7 expressed by the gene transfected into ST cells. Hemaglutinin tag (HA, light
blue) was inserted after signal peptide (blue). (B) Protein 7 expression levels for the three ST-HA-7 selected cellular clones (C1, C2 and C3), were
analyzed by immunofluorescence (left). Tagged protein 7 was detected with an anti-HA antibody stained in green, and cell nucleus were stained in
blue. Percentage of HA-7 expressing cells is indicated. HA-7 protein accumulation was evaluated by Western-blot (right). HA-7 band is indicated, and
corresponds to tagged protein cleaved form (7 KDa). (C) ST cells, or ST cells expressing HA-tagged protein 7 (ST-HA-7) were used to analyze apoptosis
levels by flow cytometry. Apoptosis levels in mock, rTGEV-wt (wt) and rTGEV-D7( D7) infected cells were evaluated at 12 hpi. Annexin V-PI double
staining was performed to differentiate cells in early apoptosis (Annexin V
+,P I
2) from those in late apoptosis (Annexin V
+,P I
+) stages. (D) ST cells and
the three ST-HA-7 cell clones obtained were mock, rTGEV-wt or rTGEV-D7 infected. Total RNA was extracted at 18 hpi. Cellular RNA integrity was
analyzed using a Bioanalyzer. 28S and 18S rRNAs are indicated on the right.
doi:10.1371/journal.ppat.1002090.g009
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PLoS Pathogens | www.plospathogens.org 14 June 2011 | Volume 7 | Issue 6 | e1002090Figure 10. PP1c binding motif in genus a1 CoV protein 7. (A) Fragment from the alignment of genus a1 CoV 7a proteins. Canonical PP1c-
binding motif is represented by the red box [ELM server [105,106]]. (B) Consensus PP1 binding motif, including a short sequence (R/K)VxF (red),
surrounded by non-polar residues. This motif is present in other viral and cellular proteins, such as human simplex virus-1 (HSV-1) c134.5, African
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suggesting that this nuclease was the responsible for RNA
degradation during TGEV infection. Interestingly, 29-59OAS1
expression, which is required for RNase L activation, was similarly
increased after infection with both rTGEV-wt and rTGEV-D7
viruses. These results suggested that protein 7 may be modulating
the 29-59OAS pathway at a level prior to RNase L activation
(Figure 14). Activation of 29-59OAS by dsRNA leads to the
synthesis of 59-triphosphorylated, 29-59-oligoadenylates (29-59A)
required for RNase L dimerization and activation. The 29-59A are
highly unstable due to their potential dephosphorylation at the
59end by general phosphatases, leaving the core oligoadenylate
that does not efficiently activate RNase L [117]. We propose that
the complex PP1-protein 7 may counteract RNase L activation
through the dephosphorylation of 29-59A. In fact, native TGEV
protein 7 provided in trans reduced RNA degradation, while a
protein 7 mutant that did not bound PP1 was unable to decrease
RNA degradation. To our knowledge, this is the first report
involving PP1 protein on the dsRNA induced RNA degradation
pathway. Surprisingly, viral mRNAs were not differentially
degraded after infection with rTGEV-wt or rTGEV-D7, indicating
that these mRNAs may be hidden from nuclease activity. Initially,
protection of these mRNAs could be mediated by their sheltering
in double-membrane vesicles (DMVs), induced by CoV infection,
and identified in MHV [28], SARS-CoV [29], and TGEV
infected cells (A. Nogales, L. Enjuanes and F. Almaza ´n,
unpublished results). DMVs may provide an environment for
viral RNA synthesis, and prevent the action of components of host
defenses, such as antiviral nucleases. The mechanisms for viral
mRNA protection at later stages of the viral cycle will require
further studies.
We demonstrated that rTGEV-D7 showed an enhanced CPE,
in relation to that caused by rTGEV-wt, which was a consequence
of the acceleration of apoptosis characterized by a faster activation
of caspase 3. In agreement with our results, it has previously been
described that the activation of PKR and 29-59OAS/RNase L
pathways generally leads to apoptosis [118,119]. Furthermore,
apoptosis initiated by RNase L requires caspase 3 activity [120].
Interestingly, the growth kinetics of both viruses was similar,
indicating that the increased antiviral response and apoptosis, did
not compromise virus replication. It has been previously described
that inhibition of TGEV-induced apoptosis did not enhance viral
production [63]. Similarly, in other CoVs, such as SARS-CoV or
MHV, downregulation of PKR or RNase L, respectively, did not
affect virus growth [96,121]. Altogether these results suggest that,
at least for these CoVs, the dsRNA-activated response did not
affect viral replication. Nevertheless, all these CoVs have
developed strategies to counteract the dsRNA antiviral response
[33,122,123]. These strategies could control the deleterious effect
that an exacerbated antiviral response may cause in the host, and
therefore in long term virus survival [124]. In fact, rTGEV-D7
virus showed an accelerated growth kinetics in vivo compared to
rTGEV-wt. This effect was probably due to a premature cell death
in the rTGEV-D7 infected animal tissue that promoted a faster
initial propagation of the virus.
To generate the rTGEV-D7 analyzed here, minimal modifica-
tions required to avoid gene 7 expression were introduced in a
TGEV-wt backbone. A previously evaluated rTGEV without gene
7 expression showed full attenuation, with 100% survival of
infected piglets [52], what is at variance (but not in contradiction)
with the results presented in this work. Fortunately, the two
deletion mutant viruses used in the Ortego et al 2003 paper and
the one used here are completely different. The mutant virus in the
Ortego’s paper was derived from a already highly attenuated virus,
only causing 20% piglet death after virus administration. It is
essential to realize that this virus already included many additional
attenuating genome changes: (i) five engineered restriction sites
preceding genes 3a, E, M, N and 7; (ii) the duplication of
sequences preceding these genes, required to avoid gene
overlapping. Furthermore this duplicated sequences, located close
to the gene TRS, contained an additional TRS that regulate the
expression levels of each gene, what probably influenced the
expression levels of these viral genes; and (iii) a deletion spanning
21 nt upstream ORF7 start codon and the first 17 nt of this ORF,
that was introduced to prevent the expression of gene 7. In
contrast, the TGEV deletion mutant used in this work only
included a point mutation in gene 7 CS and a 7 nt deletion to
prevent the production of protein 7. Therefore, the changes
observed in the pathogenicity of the Ortego’s recombinant virus
could not be exclusively assigned to gene 7 absence, in contrast to
the results presented in this paper.
In general, viral infection leads to a strong antiviral state in
infected and neighboring cells [65]. We postulate that the balance
between enhanced apoptosis and the bystander effect compro-
mised and limited rTGEV-D7 virus tissue dissemination. Prelim-
inary results from high throughput gene expression analysis
supported this proposal (data not shown). In fact, in agreement
with this postulate, rTGEV-D7 infected piglets showed an
accelerated pathology when compared with the rTGEV-wt
infected ones. Furthermore, the recovery from the inflammatory
response was slower in rTGEV-D7 infected animals than in
rTGEV-wt ones as lungs infected by the rTGEV-D7 showed more
lesions at 4 dpi than those infected with the rTGEV-wt. Current
work in our lab is directed at analyzing whether the removal of
gene 7 in rTGEV leads to an infection with an enhanced innate
immune response.
The results obtained suggested that while a balanced immune
response promotes virus clearance and tissue reparation, an
exacerbated innate immune response could result in immune
pathology and subsequent tissue damage, as observed in rTGEV-
D7 infected piglets. Similar effects have been described for other
viruses, such as human hepatitis C virus [125], in which tissue
damage was associated to the development of an exacerbated host
antiviral response and not with viral replication. Moreover, piglets
infected with a TGEV virulent enteric strain lacking protein 7
expression (rTGEV-SC11-D7), developed a faster and more
pronounced clinical disease. High pathogenicity resulted in a
more rapid host elimination, affecting virus long-term survival as
the host is essential for virus propagation. From an evolutionary
point of view, our results suggested that CoVs genus a1 might have
swine fever virus (ASFV) DP71L, human papilomavirus (HPV) E6 oncoprotein, and human growth arrest DNA-damage 34 (GADD34). GenBank
accession numbers are ADB28914.1, P36313, Q65212, ACR78108 and O75807, respectively. Dark blue, non-polar aa; light blue, basic aa; green, polar
aa; and red, PP1 binding motif core sequence. (C) Proposed model for protein 7 function during TGEV infection. (D) Coimmunoprecipitation of TGEV
protein 7 and PP1. TGEV protein 7-PP1 interaction was evaluated using ST cells, ST-HA-7 cells (7), or ST cells transiently expressing SARS-CoV E protein
(E), or a protein 7 mutant lacking the PP1 binding motif (7-mut). Cell extracts were incubated with anti-HA agarose. Input, flow through (FT), and final
elution (CoIP) samples were resolved by SDS-PAGE. The presence of HA-tagged proteins, PP1 and eIF2a was analyzed by Western-blot using specific
antibodies.
doi:10.1371/journal.ppat.1002090.g010
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PLoS Pathogens | www.plospathogens.org 16 June 2011 | Volume 7 | Issue 6 | e1002090Figure 11. Effect of mutated protein 7 provided in trans on RNA degradation and eIF2a phosphorylation. ST cells, or ST cells expressing
native TGEV protein 7 or the mutated protein 7 lacking PP1 binding motif were used. Cells were mock infected or rTGEV-wt (wt) and rTGEV-D7( D7)
infected. (A) Total RNA was extracted at 18 hpi and cell RNA integrity was analyzed using a Bioanalyzer. 28S and 18S rRNAs are indicated on the right.
(B) Total protein was extracted at 10 hpi and eIF2a and eIF2a-P protein levels were analyzed by Western-blot. Protein amounts were estimated by
densitometry, and the ratio of eIF2a-P to total eIF2a was represented. Error bars represented the standard deviation of three independent
experiments.
doi:10.1371/journal.ppat.1002090.g011
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preventing overwhelming tissue damage due to an exacerbated
innate immune response. Protein 7 would then benefit both the
host, reducing the pathology caused by the infection, and the virus,
allowing longer virus persistence and dissemination.
Materials and Methods
Ethics statement
Animal experimental protocols were in strict accordance with
EU guidelines 2010/63/UE, and Spain national law RD 1201/
2005, about protection of animals used for experimentation and
other scientific purposes, and national law 32/2007, about animal
welfare in their exploitation, transport, experimentation and
sacrifice. The experiments were performed in an animal facility
at Pfizer Animal Health, Girona (Permit numbers G9900005 and
G9900007), and were approved by the in site ethical review
committee (Comite `E `tic d’Experimentacio ´ Animal).
Cells
Baby hamster kidney (BHK) cells stably transformed with the
porcine amino peptidase N gene (BHK-pAPN) [126] were grown
in Dulbecco’s modified medium (DMEM) supplemented with 5%
fetal bovine serum (FBS) and G418 (1.5 mg/ml) as a selection
agent. Swine testis (ST) cells were grown in DMEM supplemented
with 10% FBS [127].
Generation of ST cells expressing TGEV protein 7
The gene for TGEV protein 7, with hemaglutinin tag (HA)
inserted after the signal peptide, cloned in HindIII-EcoRI
restrictions sites in the plasmid pcDNA 3.1, was purchased from
GenArt (Germany). Four micrograms of pcDNA 3.1-HA-7 were
linearized with SmaI, and purified using QIAquick Kit (Qiagen)
according to the manufacturers specifications. The linearized
plasmid was used for reverse transfection of ST cells with 12 mlo f
Lipofectamine 2000 (Invitrogen), as recommended by the
manufacturer. Cells were grown in DMEM supplemented with
10% FBS and G418 (1.5 mg/ml) as a selection agent. Cells were
cloned and positive clones for HA-7 expression, by immunofluor-
esce and Western-blot, were amplified.
Generation of ST cells transiently expressing TGEV
protein 7-mut or SARS-CoV E protein
A pcDNA 3.1 plasmids, with TGEV 7-mut gene cloned in
HindIII-EcoRI restrictions sites, was purchased from GenArt
(Germany). This plasmid, pcDNA3.1-7-mut, encodes TGEV
protein 7 with a deletion comprising amino acids 59 to 62, which
include the PP1 binding motif (R/K)VxF, with an HA tag inserted
after the signal peptide. Plasmid pcDNA3.1-E, encoding SARS-
CoV E protein, with an HA tag in its amino-terminus, was
previously obtained in our laboratory (E. Alvarez, M. L. DeDiego
and L. Enjuanes, unpublished results). For transient expression
experiments, circular plasmids were used for reverse transfection
of ST cells as described above.
Construction of the plasmid pBAC-TGEV-D7
A recombinant TGEV virus was engineered using a TGEV-
SPTV genetic background, with respiratory tropism and adapted
to tissue cultures [57]. The mutations required to knock down
gene 7 expression were introduced by overlapping PCR using as a
template the plasmid pSL-3EMN7, comprising nucleotides 20,372
to 28,087 of TGEV genome [128]. Overlapping PCR fragments,
with point mutations and deletions, were amplified using
oligonucleotides DORF7 VS (59-GCTCGTCTTCCTCCAT-
GCTGTATTTAT-39) and DORF7 RS (59-GATAATTGAT-
GAGGTAACGAACTGAGCTCGTCTTCGTTACCTATC-39).
The final PCR product (2700 bp), amplified with outer
oligonucleotides DORF7 VS-Oli 4 SphIR S( 5 9-CATAGCACAA-
Figure 12. In vivo growth kinetics of rTGEV-D7 virus. (A) Two- to three-day-old piglets were inoculated with 1610
7 pfu/pig of rTGEV-wt and
rTGEV-D7 viruses by two routes (oral and nasal) in combination. At 0.5, 1, 2, 3, 4 and 5 days post inoculation two animals per group were sacrificed,
and the lungs were harvested. rTGEV-wt (blue) and rTGEV-D7 (red), recovered from lung, were titrated. Triangles indicated sentinel animals. (B) Two-
to three-day-old piglets were inoculated with 1610
7 pfu/pig of rTGEV-SC11-wt and rTGEV-SC11-D7 viruses by three routes (oral, intranasal and
intragastric) in combination. At indicated days post inoculation two animals per group were sacrificed, and the lung and the gut were harvested.
rTGEV-SC11-wt (blue) and rTGEV-SC11-D7 (red) titers in gut are represented. Triangles indicate sentinel animals. Error bars indicate the standard
deviation from three independent experiments.
doi:10.1371/journal.ppat.1002090.g012
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PLoS Pathogens | www.plospathogens.org 18 June 2011 | Volume 7 | Issue 6 | e1002090Figure 13. Lung histopathology caused by rTGEV-D7 infection. Two- to three-day-old piglets were inoculated with 1610
7 pfu/pig of rTGEV-
wt and rTGEV-D7. Lung samples, collected at 1 and 4 days post infection, were stained with hematoxylin-eosin (H&E). Pictures were obtained with a
10x objective. TGEV membrane protein (M) and cleaved caspase 3, were also immunodetected with specific antibodies. Pictures were obtained with a
20x objective.
doi:10.1371/journal.ppat.1002090.g013
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1 SphIV S( 59-GGAGGATTGGGAAGACAATAGCAGG-
CATGCTGGGG-39), was digested with SphI and cloned in the
same restriction site of pSL-3EMN7, leading to pSL-3EMND7. To
generate the plasmid pBAC-TGEV-SPTV-D7, pSL-3EMND7 was
digested with SfoI-BamHI. This fragment, containing nt 23,464 to
28,700 of the TGEV genome, and including the mutations, was
cloned in the same restriction sites of the full-length pBAC-TGEV-
SPTV
FL [129]. To generate a rTGEV-D7 virus with both enteric
and respiratory tropism a TGEV-SC11 virus backbone was used
[57]. To this end, the pSL-3EMND7 SfoI-BamHI fragment was
cloned in the same restriction sites of the full-length pBAC-TGEV-
SC11
FL [129]. All cloning steps were checked by sequencing of the
PCR fragments and cloning junctions.
Transfection and recovery of infectious virus
BHK-pAPN cells were grown to 95% confluence on 35-mm-
diameter plates and transfected with 4 mg of infectious cDNA
using 12 ml of Lipofectamine 2000 (Invitrogen), according to the
manufacturer’s specifications. After 6 h of incubation at 37uC,
cells were trypsinized and plated over a confluent ST monolayer
grown in 35-mm-diameter plate. Recombinant TGEV (rTGEV)
viruses were recovered, grown and titrated as previously described
[130,131].
RNA extraction and analysis
One day after confluence ST cells, grown on 35-mm-diameters
plates, were infected at a multiplicity of infection (moi) of 5. Total
intracellular RNA was extracted at different hours post-infection
(hpi) using the RNeasy Mini Kit (Qiagen), according to the
manufacturer’s instructions. Viral sg mRNAs were evaluated by
Northern blot and RT-qPCR analyses, following standard
procedures set up in our laboratory [131,132]. Cellular gene
expression was analyzed by using a custom TaqMan gene
expression assay (Applied Biosystems) specific for porcine 29,59oli-
goadenylate synthetase 1 (29,59OAS1) (Table 1), and growth arrest
DNA-damage 34 (GADD34) (Table 1). Data were acquired with
an ABI PRISM 7000 sequence detection system and analyzed
with ABI PRISM 7000 SDS version 1.2.3 software (Applied
Biosystems). Total cell RNA integrity was evaluated with a
Bioanalyzer 2100 (Agilent Technologies) following the manufac-
turer `s recommendations, and analyzed with 2100 Expert software
(Agilent Technologies). Four micrograms of polyinosynic-poly-
cytidylic acid [Poly (I:C), Sigma] were used for reverse transfection
of ST cells with 12 mg of Lipofectamine 2000 (Invitrogen), as
recommended by the manufacturer. Total RNA was extracted
16 hours post transfection, and cell RNA integrity was analyzed as
described above. For apoptosis inhibition experiments, caspase
inhibitor inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylk-
etone (ZVAD.fmk) was added to the cell culture medium at a
concentration of 100 mM as previously described [63]. Total RNA
was extracted 18 hours post infection, and cell RNA integrity was
analyzed as described above.
Expression of RNase L system from recombinant vaccinia
viruses
To evaluate the cellular RNA degradation by the 2-5OAS/
RNase L system, three recombinant vaccinia viruses, vvT7, vvRL
and vv2-5AS, were used as previously described [84]. Expression
of RNase L from vvRL, was under the control of T7 promoter
Figure 14. dsRNA induced antiviral pathway. Schematic overview of the dsRNA-induced antiviral pathway analyzed. Differential effects
observed during rTGEV-D7 infection are in red. PP1, the proposed target of protein 7, is in blue.
doi:10.1371/journal.ppat.1002090.g014
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produced by vvT7 and vv-2-5AS respectively, was constitutive.
ST cells were infected at a moi of 2 with vvT7 or vvT7, vvRL and
vv2-5AS. Total RNA was harvested at 24 hpi, and analyzed by a
Bioanalyzer as described above.
Protein analysis by Western blotting
ST cells were infected at a moi of 5, harvested at different hpi,
and protein extracts were obtained as previously described [59].
When protein phosphorylation levels were analyzed, a phosphatase
inhibitor cocktail (PhosSTOP, Roche) was added to the extraction
buffer. Cell lysates were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were
transferred to a nitrocellulose membrane (Hybond-C, GE Health-
care) and analyzed as described [45]. The membranes were
incubated with polyclonal antibodies (pAbs) specific for active
Caspase 3 protein(abcam,1:10,000),PKR (SantaCruz,1:200), BiP
(Abcam, 1:500), eIF2a (Santa Cruz, 1:2000), phosphorylated eIF2a
(Invitrogen, 1:500) and PP1c (Santa Cruz, 1:200). Monoclonal
antibodies (mAbs) specific for HA (Sigma, 1:1000), total PKR
(Santa Cruz, 1:1000), PP1c (Santa Cruz, 1:1000) and b-Actin
(Abcam, 1:10,000) were also used. Protein accession numbers are
detailed in Table 1. Bound primary antibodies were detected with
horseradish peroxidase-conjugated antibodies specific for the
different species, using the Immobilon Western chemiluminescent
substrate (Millipore), following the manufacturers recommenda-
tions. Protein amounts were estimated by densitometric analysis
using Quantity One 4.6.3 software (BioRad). At least three different
experiments and appropriate gel exposures were used in all cases
with similar results. In addition, different exposures of the same
experiment were analyzed to assure that data were obtained from
films within linear range.
Immunofluorescence
ST-HA-7 cells were fixed with 4% paraformaldehyde and
permeabilized with 0.2% saponin in phosphate-buffered saline
(PBS) and 10% FBS. Monoclonal antibody specific for HA (Sigma,
1:500) was used. Bound primary antibody was detected with
AlexaFluor488 conjugated antibody specific for mouse (Invitrogen,
1:500). Cell nucleus were stained with 49,6-diamidino-2-pheny-
lindole (DAPI) (Sigma, 1:200).
Metabolic labeling
One day post-confluence ST cells, grown on 35-mm-diameters
plates were infected at a moi of 1 to avoid strong cytopathic effect
(CPE). The cells were incubated 30 min in cysteine- and
methionine- free modified Eagles medium with 10% FBS
(starvation medium). The medium was then replaced by starvation
medium containing 50 mCi
35S/ml labeled Met and Cys (Taper).
Cells were incubated at 37uC for 1 hour, washed with PBS
containing 50 mM Ca
2+ and 50 mM Mg
2+, and pelleted. The cells
were broken in 50 ml of lysis buffer [59] supplemented with a
nuclease mix (10U DNaseI from Roche, 10 mg RNase A from
Qiagen) and 50 ml of SDS-PAGE loading buffer 2x [134]. Total
protein lysates were subjected to one freeze-thaw cycle and then
boiled at 95uC for 10 min, 15 ml of each sample were separated by
5-15% gradient SDS-PAGE. The gel was dried under vacuum
onto Whatman 3 MM paper and exposed for protein product
visualization. Label was estimated by densitometric analysis as
described above.
Cell death analysis
To quantify cell death levels, ST cells were permeabilized and
stained with vital dye propidium iodide (PI) (Roche) following
standard procedures (Nicoletti I., 1991). The cell death population
(genomic content ,2 n) was quantified by flow cytometry.
Apoptosis was evaluated by flow cytometry using fluorescein
isothiocyanate (FITC) conjugated Annexin V (Roche), specifically
binding apoptotic cells, as previously described [61]. Annexin V
plus PI double staining was performed to differentiate cells in early
apoptosis (Annexin V
+,P I
2) from those in late apoptosis (Annexin
V
+,P I
+) stage.
Co-immunoprecipitation
Cell extracts from ST-HA-7 cells, expressing TGEV HA-tagged
protein 7, or ST cells transiently expressing HA-tagged corona-
virus proteins 7-mut or E were incubated with a mAb anti-HA
agarose conjugated (1:1, Sigma), following the manufacturers
recommendations. The presence of viral proteins 7, 7-mut and E,
and cell proteins PP1 and eIF2a in the eluted samples was
analyzed by Western-blot using specific antibodies as described
above.
In vivo growth kinetics
Two- to three-day-old non-colostrum-deprived piglets, born
from TGEV seronegative sows, were inoculated with virus
(1610
7 pfu/pig) following standard procedures [57]. Briefly, for
respiratory tropism viruses animals were infected by two different
routes (oral and intranasal) in combination. For enteric tropism
viruses, animals were infected by three routes (intranasal, oral and
intragastric) in combination. Infected animals were monitored
daily to detect symptoms of disease and death. At 0.5, 1, 2, 3, 4
and 5 days post-inoculation (dpi) two animals per group were
Table 1. Accession numbers of proteins mentioned in the
text.
PROTEIN SPECIES
(a) ID DATABASE
b-actin Porcine Q7M3B0 UniProtKB (unreviewed)
Human P60709 UniProtKB
BiP Porcine P34935 UniProtKB
Human P11021 UniProtKB
Caspase 3 Porcine Q95ND5 UniProtKB
eIF2a Porcine P20460
(b) UniProtKB
Human Q9BY44 UniProtKB
eIF4G Porcine –
(c) –
Human Q04637 UniProtKB
GADD34 Porcine ENSSSCT00000003504 ENSEMBL
OAS1 Porcine Q29599 UniProtKB
PERK Porcine ENSSSCP00000008763 ENSEMBL
Human Q9NZJ5 UniProtKB
PKR Porcine Q865A4 UniProtKB (unreviewed)
Human P19525 UniProtKB
PP1 Porcine – –
Human P62136 UniProtKB
RNaseL Porcine A5H025 UniProtKB (unreviewed)
Human Q05823 UniProtKB
(a) The work was performed in porcine cells, but human IDs are also provided
when antibodies for human proteins were used.
(b) Available sequence corresponds to a 70 aa fragment.
(c) Sequence not available.
doi:10.1371/journal.ppat.1002090.t001
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representative samples, tissue extracts were obtained by homog-
enizing the whole organs at 4uC by using a Pro-250 tissue
homogenizer (Fisher Scientific). Virus titers were determined in
lung extracts following procedures set up in the laboratory [57].
Immunohistochemistry
Lung representative sections were fixed with 4% paraformal-
dehyde and stored in 70% ethanol at 4uC. Paraffin embedding,
sectioning and hematoxylin-eosin staining (H&E) were performed
by the histology service in the National Center of Biotechnology
(CNB, Spain). 4 micron sections were immunostained for TGEV
membrane (M) protein and cleaved caspase 3. Briefly, samples
were deparaffined at 60uC and rehydrated by successive
incubations in 100% xylol, 100% ethanol and 96% ethanol.
Endogenous peroxidase was blocked at 37uC in darkness with 1%
H2O2 diluted in methanol. For cleaved caspase 3 detection, tissue
sections were boiled in citrate buffer (8.2 mM sodium citrate;
1.8 mM citric acid) pH 6.5. Unspecific binding was blocked with
3% bovine serum albumin (BSA) in PBS. Samples were incubated
with a mAb specific for TGEV M protein (3B.B3, 1:100) [130] or
with a pAb specific for active caspase 3 protein (abcam, 1:300),
respectively. Bound primary antibodies were detected with
biotinylated antibodies specific for the different species, using the
ABC Peroxidase Staining Kit and Metal Enhanced DAB Substrate
Kit (Pierce), following the manufacturers recommendations.
Supporting Information
Figure S1 Porcine GADD34 expression. The expression of
porcine GADD34, during rTGEV-wt (blue) or rTGEV-D7 (red)
infections at indicated hpi, was analyzed by RT-qPCR. Error bars
indicate the standard deviation from three independent experi-
ments. r.u., relative units.
(TIF)
Figure S2 Decreased eIF2a-P by expression of TGEV protein 7
in trans. (A) ST cells and ST-HA-7 clones C1, C2 and C3 were
infected with rTGEV-wt or rTGEV-D7. Total RNA was extracted
at 10 hpi and porcine GADD34 expression was analyzed by RT-
qPCR. r.u., relative units. Error bars represented the standard
deviation of three independent experiments. (B) ST cells and ST-
HA-7 clones C1 and C3 were infected with rTGEV-wt or rTGEV-
D7. Total protein was extracted at 10 hpi and eIF2a and eIF2a-P
protein levels were analyzed by Western-blot. Protein amounts
were estimated by densitometry, and the ratio of eIF2a-P to total
eIF2a was represented. Error bars represented the standard
deviation of three independent experiments.
(TIF)
Figure S3 Effect of protein 7 on kinases implicated in eIF2a
phosphorylation. (A) Scheme of eIF2a/eIF2a-P equilibrium
influenced by PKR, PERK and PP1 activity. (B) Evaluation of
phosphorylated PKR (PKR-P), total PKR and BiP accumulation
during rTGEV-wt or rTGEV-D7 infections, at indicated hpi, by
Western-blot using specific antibodies. b-actin was detected as
loading control. (C) Analysis of PP1 accumulation in ST cells
infected with rTGEV-wt or rTGEV-D7 at indicated times post
infection, by Western-blot using a specific antibody. b-actin was
detected as loading control.
(TIF)
Figure S4 Interaction between PP1 and TGEV protein 7 in the
context of TGEV infection. (A) ST mock infected cells, or ST-HA-7
cells infected with rTGEV-D7 were used for immunoprecipitation.
Cell extracts from 16 hpi were incubated with anti-HA agarose.
Input, flow through (FT), and final elution (CoIP) samples were
resolved by SDS-PAGE. The presence of HA-tagged protein 7 and
PP1 was analyzed by Western-blot using specific antibodies. (B) ST-
HA-7 mock infected cells, or infected with rTGEV-wt or rTGEV-D7
viruses were used for immunoprecipitation as in (A). Co-immuno-
precipitated (Co-IP) samples from different experiments were
resolved by SDS-PAGE, and HA-tagged protein 7 and PP1 were
detected by Western-blot. The graph represents the ratio between
PP1 and HA-7 protein, estimated by densitometry. Error bars
represent the standard deviation from the different experiments.
(TIF)
Figure S5 In vivo rTGEV-SC11-D7 virulence. Three-day-old
piglets were inoculated with 1610
7 pfu/animal of rTGEV-SC11-
wt or rTGEV-SC11-D7 viruses, by three routes (oral, intranasal
and intragastric) in combination. (A) Clinical symptoms were
analyzed during the experiment. The degree of diarrhea was
represented: from 0, meaning healthy animal, to 3, meaning acute
diarrhea. (B) Number of surviving piglets at different days post
inoculation.
(TIF)
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